HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BENN, P. A. Articles by BEAZOGLOU, T. Search for Related Content PubMed PubMed Citation Articles by BENN, P. A. Articles by BEAZOGLOU, T.

Cost-Effectiveness of Estimating Gestational Age by Ultrasonography in Down Syndrome Screening

From the Division of Human Genetics, Department of Pediatrics, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, and the Department of Pediatric Dentistry, University of Connecticut Health Center, Farmington, Connecticut.

Address reprint requests to: Peter A. Benn, PhD, Division of Human Genetics, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030-6140, E-mail: benn{at}nso1.uchc.edu

Objective: To quantify the financial benefits of using ultrasound estimation of gestational age in maternal serum screening for Down syndrome.

Methods: Maternal age-specific sensitivity and false-positive rates for Down syndrome were derived for the triple test (alpha-fetoprotein, hCG, and unconjugated estriol) using gestational age based on ultrasound dating and also time from the last menstrual period (LMP). These rates were entered into a formula to determine the societal financial net benefit of Down syndrome screening. The average per-case net benefits of ultrasound- and LMP-dated pregnancies were then compared. Average net benefits were also calculated separately with ultrasound versus LMP dating for triple tests referred to our laboratory, and the additional costs associated with any post-test ultrasound scans, repeat testing, or recalculations were estimated.

Results: The use of ultrasound dating resulted in higher detection rates for Down syndrome and lower false-positive rates, which translated into an average per-case savings to society of $33.54. For women referred to our program with LMP dating, there was an average reduction of $31.60 in net benefits, plus added costs of $14.39 attributable to extra ultrasound, repeat testing, and recalculation.

Conclusion: When ultrasound dating is available before serum screening, it should be used preferentially to establish Down syndrome risk. Routine first-trimester ultrasound examination can be justified for women with a known LMP if the cost of the ultrasound examination is less than $46.

This article has been cited by other articles:

				J. F. X. EGAN, P. BENN, A. F. BORGIDA, J. F. RODIS, W. A. CAMPBELL, and A. M. VINTZILEOS Efficacy of Screening for Fetal Down Syndrome in the United States From 1974 to 1997 Obstet. Gynecol., December 1, 2000; 96(6): 979 - 985. [Abstract] [Full Text] [PDF]